Early Life Intervention in Pediatrics Supported by E-health - SMOKE

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Mar 7, 2024

Keywords

ClinConnect Summary

The SMOKE clinical trial is looking at ways to help parents reduce smoking in their homes to protect their children from secondhand smoke exposure, which can lead to health issues like asthma. The study will test an online application designed for parents to see if it helps lower the levels of a chemical found in urine that indicates exposure to tobacco smoke. This is important because children who breathe in secondhand smoke are at higher risk for developing serious health problems.

To participate in this trial, children must be under 6 years old and live in a home where at least one parent smokes. Parents need to be German-speaking, and they must give consent for their child to take part. The study is open to all genders and ethnic backgrounds. If you decide to join, you'll be part of a program that aims to support families in making healthier choices and reducing smoking in the home, which can help improve your child's health over time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: younger than 6 years
• • Exposed to second-hand smoke at home (at least one parent smoking)
• • German speaking parent
• • All sex and ethnic backgrounds
• • Signed informed consent form from parent
• • Children live/grow-up in the same household as the parental participant
• • Referred by a health care professional (e.g. physician, midwife, nurse, other professions)
• Exclusion Criteria:
• • Participation in another study/trial targeting similar outcomes
• • Participation in an active smoking cessation programme